STAT6 siRNA matrix-loaded gelatin nanocarriers: formulation, characterization, and ex vivo proof of concept using adenocarcinoma cells.

Youngren SR, Tekade RK, Gustilo B, Hoffmann PR, Chougule MB. STAT6 siRNA matrix-loaded gelatin nanocarriers: formulation, characterization, and ex vivo proof of concept using adenocarcinoma cells. Biomed Res Int. 2013; 2013:858946.

View in: PubMed

subject areas

Adenocarcinoma
Cell Line, Tumor
Cell Survival
Chemistry, Pharmaceutical
Gelatin
Gene Transfer Techniques
Humans
Lung Neoplasms
Molecular Weight
Nanocapsules
Nanomedicine
Particle Size
RNA Stability
RNA, Small Interfering
STAT6 Transcription Factor

authors with profiles

Peter R. Hoffmann, PhD
Mahavir Chougule, PhD, MPharm, B Pharm

RCMI CC is supported by the National Institute on Minority Health and Health Disparities, National Institutes of Health (NIH), through Grant Number U24MD015970. The contents of this site are solely the responsibility of the authors and do not necessarily represent the official views of the NIH

For technical support please contact support